Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid after denosumab in osteoporosis
2015-005529-37Phase 4Completed
- Sponsor
- Bente Lomholt Langdahl
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in osteoporosis (3 arms), sponsored by Bente Lomholt Langdahl. Primary endpoint: Co-primary endpoint. Started Dec 2015; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2015-005529-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005529-37.